BCV
BIIB icon

Banque Cantonale Vaudoise’s Biogen BIIB Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
11,496
+3,568
+45% +$683K 0.34% 54
2026
Q1 		$1.45M Buy
7,928
+4,466
+129% +$823K 0.05% 314
2025
Q4 		$609K Sell
3,462
-11,683
-77% -$1.91M 0.02% 429
2025
Q3 		$2.12M Sell
15,145
-3,335
-18% -$451K 0.08% 245
2025
Q2 		$2.32M Buy
18,480
+8,648
+88% +$1.08M 0.09% 214
2025
Q1 		$1.34M Buy
+9,832
New +$1.41M 0.06% 302
2024
Q3 		$1.02M Sell
5,259
-2,059
-28% -$431K 0.04% 318
2024
Q2 		$1.7M Buy
7,318
+4,401
+151% +$956K 0.07% 262
2024
Q1 		$630K Sell
2,917
-1,505
-34% -$352K 0.02% 403
2023
Q4 		$1.15M Sell
4,422
-1,391
-24% -$342K 0.05% 317
2023
Q3 		$1.5M Sell
5,813
-659
-10% -$176K 0.07% 221
2023
Q2 		$1.84M Buy
6,472
+336
+5% +$100K 0.09% 200
2023
Q1 		$1.71M Buy
6,136
+200
+3% +$55.3K 0.08% 228
2022
Q4 		$1.64M Sell
5,936
-611
-9% -$173K 0.09% 215
2022
Q3 		$1.75M Buy
6,547
+2
+0% +$425 0.1% 196
2022
Q2 		$1.33M Sell
6,545
-1,152
-15% -$235K 0.07% 278
2022
Q1 		$1.62M Sell
7,697
-161
-2% -$35K 0.07% 272
2021
Q4 		$1.89M Sell
7,858
-388
-5% -$99.8K 0.07% 251
2021
Q3 		$2.33M Buy
8,246
+280
+4% +$91.8K 0.1% 194
2021
Q2 		$2.76M Sell
7,966
-1,110
-12% -$336K 0.12% 174
2021
Q1 		$2.54M Buy
9,076
+2,026
+29% +$546K 0.13% 160
2020
Q4 		$1.73M Sell
7,050
-123
-2% -$31.7K 0.1% 192
2020
Q3 		$2.04M Sell
7,173
-2,008
-22% -$560K 0.13% 144
2020
Q2 		$2.46M Buy
9,181
+2,100
+30% +$631K 0.18% 118
2020
Q1 		$2.24M Buy
7,081
+2,000
+39% +$607K 0.19% 110
2019
Q4 		$1.51M Buy
+5,081
New +$1.41M 0.1% 221

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banque Cantonale Vaudoise's BIIB Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its Biogen (BIIB) stake by 45% in Q2 2026, buying an estimated $683K and bringing the position to 11,496 shares worth $2.48M. The position accounts for 0.34% of the portfolio, ranked #54.

Banque Cantonale Vaudoise first reported a position in BIIB in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.76M in Q2 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Banque Cantonale Vaudoise held 11,496 shares of Biogen worth $2.48M as of Q2 2026.
  • Banque Cantonale Vaudoise bought 3,568 Biogen shares in Q2 2026, an estimated $683K.
  • Biogen made up 0.34% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #54 holding.
  • Banque Cantonale Vaudoise first reported a position in Biogen in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's Biogen position peaked at $2.76M in Q2 2021.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.